Time to Study Immune Checkpoint Inhibitors in Patients With HIV Infection and Cancer

JCO Oncol Pract. 2020 Jun;16(6):327-328. doi: 10.1200/OP.20.00074. Epub 2020 Mar 11.

Authors

Susan Swindells¹, Alan L Landay²

Affiliations

¹ University of Nebraska Medical Center, Omaha, NE.
² Rush University Medical Center, Chicago, IL.

PMID: 32160135
DOI: 10.1200/OP.20.00074

No abstract available

Publication types

Comment

MeSH terms

HIV Infections* / drug therapy
Humans
Immune Checkpoint Inhibitors
Immunotherapy
Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors